| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | - | - | - | - | - | - |
| 1 | - | - | - | - | - | - | - | - | - | - | - |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | 146.0 | 146.0 |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 204 |
| 1 | 6 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 2721 |
| 1 | 3119 |
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 146
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 1.0
Columnar completeness: 0.05
Area completeness: 0.24
Cell size (columns): 42
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
| instance | NT | total connections | connections /#aMe_TBD1 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe1 (R) | GABA | 80 | 80.0 | 14.9% | 14.9% |
| 1 | LPT51 (R) | Glu | 77 | 77.0 | 14.4% | 29.3% |
| 2 | MeVPaMe1 (L) | ACh | 73 | 73.0 | 13.6% | 42.9% |
| 3 | aMe3 (R) | Glu | 53 | 53.0 | 9.9% | 52.8% |
| 4 | aMe6b (R) | ACh | 31 | 31.0 | 5.8% | 58.6% |
| 5 | MeVPaMe1 (R) | ACh | 26 | 26.0 | 4.9% | 63.4% |
| 6 | MeLo3b (R) | ACh | 21 | 21.0 | 3.9% | 67.4% |
| 7 | MeVPaMe2 (L) | Glu | 19 | 19.0 | 3.5% | 70.9% |
| 8 | LoVP96 (R) | Glu | 17 | 17.0 | 3.2% | 74.1% |
| 9 | MeVP63 (R) | GABA | 17 | 17.0 | 3.2% | 77.2% |
| 10 | aMe12 (R) | ACh | 15 | 15.0 | 2.8% | 80.0% |
| 11 | MeVCMe1 (R) | ACh | 10 | 10.0 | 1.9% | 81.9% |
| 12 | LoVC19 (R) | ACh | 9 | 9.0 | 1.7% | 83.6% |
| 13 | aMe5 (R) | ACh | 6 | 6.0 | 1.1% | 84.7% |
| 14 | MeVP29 (R) | ACh | 6 | 6.0 | 1.1% | 85.8% |
| 15 | MeVP62 (R) | ACh | 6 | 6.0 | 1.1% | 86.9% |
| 16 | LoVCLo3 (L) | OA | 4 | 4.0 | 0.7% | 87.7% |
| 17 | aMe12 (L) | ACh | 3 | 3.0 | 0.6% | 88.2% |
| 18 | Li21 (R) | ACh | 3 | 3.0 | 0.6% | 88.8% |
| 19 | Li35 (R) | GABA | 3 | 3.0 | 0.6% | 89.4% |
| 20 | LoVC23 (L) | GABA | 3 | 3.0 | 0.6% | 89.9% |
| 21 | MeLo6 (R) | ACh | 3 | 3.0 | 0.6% | 90.5% |
| 22 | MeVP14 (R) | ACh | 3 | 3.0 | 0.6% | 91.0% |
| 23 | 5-HTPMPV01 (L) | unclear | 2 | 2.0 | 0.4% | 91.4% |
| 24 | aMe2 (R) | Glu | 2 | 2.0 | 0.4% | 91.8% |
| 25 | aMe6c (R) | Glu | 2 | 2.0 | 0.4% | 92.2% |
| 26 | Dm9 (R) | Glu | 2 | 2.0 | 0.4% | 92.5% |
| 27 | HBeyelet (R) | His | 2 | 2.0 | 0.4% | 92.9% |
| 28 | LoVCLo3 (R) | OA | 2 | 2.0 | 0.4% | 93.3% |
| 29 | MeLo1 (R) | ACh | 2 | 2.0 | 0.4% | 93.7% |
| 30 | MeLo7 (R) | ACh | 2 | 2.0 | 0.4% | 94.0% |
| 31 | MeVC22 (R) | Glu | 2 | 2.0 | 0.4% | 94.4% |
| 32 | MeVCMe1 (L) | ACh | 2 | 2.0 | 0.4% | 94.8% |
| 33 | MeVPLo2 (L) | ACh | 2 | 2.0 | 0.4% | 95.1% |
| 34 | MeVPMe11 (L) | Glu | 2 | 2.0 | 0.4% | 95.5% |
| 35 | (PLP256) (R) | unclear | 1 | 1.0 | 0.2% | 95.7% |
| 36 | 5thsLNv_LNd6 (R) | ACh | 1 | 1.0 | 0.2% | 95.9% |
| 37 | aMe30 (R) | Glu | 1 | 1.0 | 0.2% | 96.1% |
| 38 | aMe4 (R) | ACh | 1 | 1.0 | 0.2% | 96.3% |
| 39 | DNp27 (R) | unclear | 1 | 1.0 | 0.2% | 96.5% |
| 40 | DNpe053 (R) | ACh | 1 | 1.0 | 0.2% | 96.6% |
| 41 | DNpe053 (L) | ACh | 1 | 1.0 | 0.2% | 96.8% |
| 42 | l-LNv (L) | unclear | 1 | 1.0 | 0.2% | 97.0% |
| 43 | LC15 (R) | ACh | 1 | 1.0 | 0.2% | 97.2% |
| 44 | Li14 (R) | Glu | 1 | 1.0 | 0.2% | 97.4% |
| 45 | Li23 (R) | ACh | 1 | 1.0 | 0.2% | 97.6% |
| 46 | LoVC22 (L) | Dop | 1 | 1.0 | 0.2% | 97.8% |
| 47 | LoVC8 (R) | GABA | 1 | 1.0 | 0.2% | 97.9% |
| 48 | LoVP18 (R) | ACh | 1 | 1.0 | 0.2% | 98.1% |
| 49 | LoVP41 (R) | ACh | 1 | 1.0 | 0.2% | 98.3% |
| 50 | LPT53 (R) | GABA | 1 | 1.0 | 0.2% | 98.5% |
| 51 | MeVC24 (R) | Glu | 1 | 1.0 | 0.2% | 98.7% |
| 52 | MeVP9 (R) | ACh | 1 | 1.0 | 0.2% | 98.9% |
| 53 | MeVPLo2 (R) | ACh | 1 | 1.0 | 0.2% | 99.1% |
| 54 | MeVPMe4 (L) | Glu | 1 | 1.0 | 0.2% | 99.3% |
| 55 | OA-AL2i3 (R) | OA | 1 | 1.0 | 0.2% | 99.4% |
| 56 | PLP080 (R) | unclear | 1 | 1.0 | 0.2% | 99.6% |
| 57 | Tm38 (R) | ACh | 1 | 1.0 | 0.2% | 99.8% |
| 58 | TmY10 (R) | ACh | 1 | 1.0 | 0.2% | 100.0% |
| instance | NT | total connections | connections /#aMe_TBD1 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe6b (R) | ACh | 3 | 3.0 | 30.0% | 30.0% |
| 1 | aMe1 (R) | GABA | 2 | 2.0 | 20.0% | 50.0% |
| 2 | aMe17c (R) | Glu | 1 | 1.0 | 10.0% | 60.0% |
| 3 | CL125 (R) | unclear | 1 | 1.0 | 10.0% | 70.0% |
| 4 | MeVC24 (R) | Glu | 1 | 1.0 | 10.0% | 80.0% |
| 5 | MeVPaMe1 (L) | ACh | 1 | 1.0 | 10.0% | 90.0% |
| 6 | SMP217 (R) | unclear | 1 | 1.0 | 10.0% | 100.0% |